Can artificial intelligence identify effective COVID-19 therapies?


In this issue of EMBO Molecular Medicine, Stebbing et al validate an artificial intelligence-assisted prediction that a drug used to treat rheumatoid arthritis could be a potent weapon against COVID-19. Using liver organoids infected with SARS-CoV-2, they confirm dual antiviral and anti-inflammatory activities, and show that its administration in four COVID-19 patients is correlated with disease improvement, paving the way for more rigorous placebo-controlled trials.

MIDAS Network Members